ARCHIVES

Clearinghouse Says In Business

This article is from The Cancer Letter archive.

Vol. 05 No. 04 | January 26, 1979

Download PDF Visit The Full Archive

Related Articles

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Folic Acid, Vitamins B6 and 12 Do Not Affect Colorectal Adenoma Risk

October 26, 2012

NCI Starts $2 Million Study On Cancer Patient Job Discrimination

January 17, 1975

In Brief: Diagnostic Imaging Cost Declines By Half as Percentage Of Health Cost In 10 Years

January 11, 1985